The FDA recommends trivalent flu vaccines for the 2025-2026 season, protecting against 2 influenza A strains and 1 influenza B strain.

"With today's action, the FDA does not anticipate any impact on timing or availability of vaccines for the American public," ...

The agency formulated its advice to manufacturers after coordinating with the CDC and Defense Department. An advisory meeting ...

The Food and Drug Administration has issued recommendations for the composition of influenza shots for the upcoming ...

After the FDA canceled a key advisory meeting, government doctors stepped in to propose a trivalent flu vaccine for the ...

The Vaccines and Related Biological Products Advisory Committee (VRBPAC) had been scheduled to meet to discuss the strains ...

After studying this year's influenza information, the recommendation is that flu vaccines for next year be trivalent, reports CNN. Also in the news, Vermont reports its first measles case in a ...

The U.S. FDA issues flu vaccine strain recommendations for 2025-2026 on its own without advisory input. Read more here.

The US Food and Drug Administration on Thursday issued recommendations for the composition of influenza shots for the ...

To maintain vaccine efficacy, WHO regularly updates influenza vaccine strains based on global epidemiological, virological, ...

To maintain vaccine efficacy, WHO regularly updates influenza vaccine strains based on global epidemiological, virological, ...

The Francis Crick Institute hosted scientists from across the world last week for a series of data presentations and ...